Capricor, Inc. announced that it has appointed Anthony Davies, Ph.D., to the newly created position of Chief Technology Officer. Dr. Davies will be responsible for manufacturing, development and expansion of Capricor's cell-based therapeutic portfolio and will report to Linda Marbán, Ph.D., Chief Executive Officer of Capricor. Dr. Davies is a 20-year veteran of the biotech industry, 15 years of which have been in cell and gene therapy.

He brings with him an impressive track record in manufacturing, operational management and commercial development, most recently as Vice President, Product Development for Geron Corporation's cell therapy programs.